Development and validation of a spontaneous preterm delivery predictor in asymptomatic women
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Preterm delivery remains the leading cause of perinatal mortality. Risk factors and biomarkers have traditionally failed to identify the majority of preterm deliveries. OBJECTIVE: To develop and validate a mass spectrometry-based serum test to predict spontaneous preterm delivery in asymptomatic pregnant women. STUDY DESIGN: A total of 5501 pregnant women were enrolled between 17(0/7) and 28(6/7) weeks gestational age in the prospective Proteomic Assessment of Preterm Risk study at 11 sites in the United States between 2011 and 2013. Maternal blood was collected at enrollment and outcomes collected following delivery. Maternal serum was processed by a proteomic workflow, and proteins were quantified by multiple reaction monitoring mass spectrometry. The discovery and verification process identified 2 serum proteins, insulin-like growth factor-binding protein 4 (IBP4) and sex hormone-binding globulin (SHBG), as predictors of spontaneous preterm delivery. We evaluated a predictor using the log ratio of the measures of IBP4 and SHBG (IBP4/SHBG) in a clinical validation study to classify spontaneous preterm delivery cases (<37(0/7) weeks gestational age) in a nested case-control cohort different from subjects used in discovery and verification. Strict blinding and independent statistical analyses were employed. RESULTS: The predictor had an area under the receiver operating characteristic curve value of 0.75 and sensitivity and specificity of 0.75 and 0.74, respectively. The IBP4/SHBG predictor at this sensitivity and specificity had an odds ratio of 5.04 for spontaneous preterm delivery. Accuracy of the IBP4/SHBG predictor increased using earlier case-vs-control gestational age cutoffs (eg, <35(0/7) vs ≥35(0/7) weeks gestational age). Importantly, higher-risk subjects defined by the IBP4/SHBG predictor score generally gave birth earlier than lower-risk subjects. CONCLUSION: A serum-based molecular predictor identifies asymptomatic pregnant women at risk of spontaneous preterm delivery, which may provide utility in identifying women at risk at an early stage of pregnancy to allow for clinical intervention. This early detection would guide enhanced levels of care and accelerate development of clinical strategies to prevent preterm delivery.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Development and validation of a spontaneous preterm delivery predictor in asymptomatic women
- Date Crossref
- 01/05/2016
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
The University of Texas Medical Branch at Galveston Department of Obstetrics & Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
University of North Carolina at Chapel Hill Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Medical University of South Carolina Department of Obstetrics and Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Baystate Medical Center Maternal Fetal Medicine pays non établi dans la noticeÉtablissement de santé
-
The Ohio State University Department of Obstetrics & Gynecology pays non établi dans la noticeUniversité ou école supérieure
-
Valleywise Health pays non établi dans la noticeÉtablissement de santé
-
Oregon Health & Science University Division of Maternal-Fetal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Intermountain Healthcare pays non établi dans la noticeÉtablissement de santé
-
Regional Obstetrical Consultants pays non établi dans la noticeÉtablissement de santé
-
Christiana Care Health System pays non établi dans la noticeÉtablissement de santé
-
Dana-Farber Cancer Institute pays non établi dans la noticeStructure de recherche
-
Department of Obstetrics and Gynecology pays non établi dans la noticeInstitution
Department of Obstetrics & Gynecology — The University of Texas Medical Branch at Galveston, Department of Obstetrics and Gynecology — University of North Carolina at Chapel Hill et Department of Obstetrics and Gynecology — Medical University of South Carolina, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.